Breastfeeding and Thyroid Cancer: Is It Safe and What To Do

Most people treated for thyroid cancer can breastfeed safely, with a few important exceptions and timing considerations. Breastfeeding is generally compatible with thyroid surgery and standard thyroid hormone replacement (levothyroxine), and many individuals can nurse without problems. ^[1] However, radioactive iodine (I‑131) therapy is not compatible with breastfeeding and requires stopping breast milk before, during, and after treatment. ^{[2] [3] [4]}

---

Who Can Breastfeed Safely

• After thyroid surgery (thyroidectomy) without radioactive iodine: Breastfeeding is typically safe as soon as you feel well enough, provided your thyroid hormone levels are adequately replaced with levothyroxine. Appropriate levothyroxine treatment can help normalize milk production in hypothyroid lactating mothers. ^{[1] [5]}
• While taking levothyroxine: Levothyroxine does pass into breast milk in small amounts, but no adverse effects have been reported, and it is considered compatible with breastfeeding. ^[5] Maintaining adequate thyroid levels supports milk supply and overall health. ^[1]

---

When Breastfeeding Is Not Safe

• During radioactive iodine (I‑131) therapy (diagnostic or therapeutic):
  • Do not breastfeed after receiving I‑131 because it concentrates in breast milk and can cause hypothyroidism in the infant. ^{[6] [7]}
  • If I‑131 is given postpartum, breastfeeding should not be restarted for the remainder of that postpartum period. ^{[8] [9] [2]}
  • To reduce radiation dose to breast tissue, stop breastfeeding and pumping for at least 6 weeks before receiving I‑131. ^{[2] [3]}

---

Key Precautions and Timing

Before I‑131 Treatment

• Fully wean and stop pumping for at least 6 weeks prior to I‑131 to lower breast uptake of radioactive iodine and protect breast tissue. ^{[2] [3]}
• Plan alternative feeding (formula or banked milk) and maintain infant care arrangements during isolation following I‑131. Infant exposure via breast milk can reach levels equal to or greater than maternal plasma, increasing risk of infant hypothyroidism. ^{[6] [4]}

If I‑131 Was Given Postpartum

• Do not restart breastfeeding at any point during the same postpartum period. ^{[8] [9] [2]}
• Your infant may need thyroid monitoring if any exposure is suspected, as radioactive iodine in milk can affect the infant’s thyroid. ^{[6] [4]}

Managing Thyroid Hormone Replacement

• Continue levothyroxine while breastfeeding; it is compatible. ^[5] Adequate dosing supports milk production and maternal health. ^[1]
• Coordinate regular thyroid function tests with your clinician to keep your levels stable, which helps maintain milk supply. ^[1]

---

Does Breastfeeding Affect Cancer Recurrence?

• Breastfeeding itself does not increase thyroid cancer recurrence risk. Most common thyroid cancers (papillary and follicular) have a favorable outlook, and recurrence patterns depend more on tumor features and initial treatment than on lactation. ^{[10] [11] [12]}
• Follow your usual surveillance plan (blood tests, imaging) as recommended by your care team. ^[12]

---

Special Situations: Iodine Emergencies and KI (Potassium Iodide)

• In rare radiation emergency scenarios requiring KI, breastfeeding may need to be temporarily suspended if prolonged dosing is required, and infants should be monitored for hypothyroidism if repeat dosing occurs. ^{[13] [14]}
• Breastfeeding can resume when local officials indicate it is safe or after evacuation and decontamination. ^[14]

---

Practical Tips for a Safer Breastfeeding Journey

• Confirm your treatment history: If you have ever received I‑131 during or after pregnancy, plan for weaning per medical guidance. ^{[8] [2]}
• Optimize thyroid levels: Take levothyroxine consistently each morning on an empty stomach and separate from calcium/iron to ensure reliable absorption, which supports milk supply. ^[1]
• Infant monitoring if exposed: If there was any chance your infant received breast milk after maternal I‑131, ask about infant thyroid function testing. ^{[6] [4]}
• Plan ahead for I‑131: Stop breastfeeding and pumping 6+ weeks before treatment, and arrange formula/banked milk for the infant. ^{[2] [3]}

---

Summary Table: Breastfeeding Safety by Treatment

Scenario	Breastfeeding Status	Key Actions
Thyroidectomy only	Generally safe	Continue breastfeeding when recovered; monitor maternal thyroid levels. [1]
On levothyroxine	Compatible	Maintain adequate dosing; helps normalize milk production. [1] [5]
Diagnostic I‑131 (capsules)	Not safe	Discontinue and do not resume during postpartum; prevent infant exposure. [6] [7] [8]
Therapeutic I‑131	Not safe	Wean and stop pumping ≥6 weeks before; do not restart postpartum. [2] [3]
Postpartum I‑131 already given	Not safe to restart	Use formula/banked milk; consider infant thyroid monitoring. [8] [4]

---

Bottom Line

• You can usually breastfeed after thyroid surgery and while taking levothyroxine, and maintaining proper thyroid hormone levels supports milk supply. ^{[1] [5]}
• Avoid breastfeeding if you receive any form of radioactive iodine (I‑131), and follow strict timing: stop milk expression at least 6 weeks before treatment and do not restart breastfeeding postpartum. ^{[2] [3] [8]}
• Work closely with your endocrinologist and pediatrician to coordinate safe timing, monitoring, and feeding plans tailored to your treatment path. ^[12]